134 related articles for article (PubMed ID: 24755835)
21. Fatal Aspergillus rhinosinusitis during induction chemotherapy in a child with acute lymphoblastic leukemia.
Vlaardingerbroek H; van der Flier M; Borgstein JA; Lequin MH; van der Sluis IM
J Pediatr Hematol Oncol; 2009 May; 31(5):367-9. PubMed ID: 19415022
[TBL] [Abstract][Full Text] [Related]
22. Cryptococcal meningitis during front-line chemotherapy for acute lymphoblastic leukemia.
Urbini B; Castellini C; Rondelli R; Prete A; Pierinelli S; Pession A
Haematologica; 2000 Oct; 85(10):1103-4. PubMed ID: 11025610
[No Abstract] [Full Text] [Related]
23. Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia.
Laughton SJ; Ashton LJ; Kwan E; Norris MD; Haber M; Marshall GM
J Clin Oncol; 2005 Apr; 23(10):2264-71. PubMed ID: 15800317
[TBL] [Abstract][Full Text] [Related]
24. Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia.
Xu XJ; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Xu WQ
Leuk Res; 2012 Aug; 36(8):1022-7. PubMed ID: 22483330
[TBL] [Abstract][Full Text] [Related]
25. Pyomyositis associated with hematological malignancy: case report and review of the literature.
Falagas ME; Rafailidis PI; Kapaskelis A; Peppas G
Int J Infect Dis; 2008 Mar; 12(2):120-5. PubMed ID: 17723316
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
27. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
[TBL] [Abstract][Full Text] [Related]
28. Bacillus cereus septicemia in a patient with acute lymphoblastic leukemia: A case report and review of the literature.
Chou YL; Cheng SN; Hsieh KH; Wang CC; Chen SJ; Lo WT
J Microbiol Immunol Infect; 2016 Jun; 49(3):448-51. PubMed ID: 23927823
[TBL] [Abstract][Full Text] [Related]
29. A dental complication involving Pseudomonas during chemotherapy for acute lymphoblastic leukemia.
Cheatham BD; Henry RJ
J Clin Pediatr Dent; 1994; 18(3):215-7. PubMed ID: 8054308
[TBL] [Abstract][Full Text] [Related]
30. Pyomyositis as the presenting feature of acute lymphocytic leukemia.
Traina ED; Crider MF; Berman D; Spoto-Cannons A
Clin Pediatr (Phila); 2008 Mar; 47(2):167-70. PubMed ID: 18258997
[No Abstract] [Full Text] [Related]
31. Idiopathic Hyperammonemia That Developed During Initial Treatment With Steroid in a Patient With Newly Diagnosed Leukemia.
Kobayashi S; Ito M; Sano H; Mochizuki K; Akaihata M; Waragai T; Ohara Y; Hosoya M; Kikuta A
J Pediatr Hematol Oncol; 2015 Aug; 37(6):e361-3. PubMed ID: 25222063
[TBL] [Abstract][Full Text] [Related]
32. The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL).
Dare JM; Moppett JP; Shield JP; Hunt LP; Stevens MC
Pediatr Blood Cancer; 2013 Dec; 60(12):E157-9. PubMed ID: 23868820
[TBL] [Abstract][Full Text] [Related]
33. Early presentation of osteonecrosis in acute lymphoblastic leukemia: Two children from the Nordic and Baltic cohort.
Mogensen SS; Harila-Saari A; Frandsen TL; Lähteenmäki P; Castor A; Kohonen I; Schmiegelow K; Mäkitie O
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28521072
[TBL] [Abstract][Full Text] [Related]
34. Mucormycosis diagnosed during induction chemotherapy in five pediatric patients with acute lymphoblastic leukemia.
Aftandilian C; Eguiguren L; Mathew R; Messner A
Pediatr Blood Cancer; 2019 Sep; 66(9):e27834. PubMed ID: 31131954
[TBL] [Abstract][Full Text] [Related]
35. Pyomyositis.
Marath H; Yates M; Lee M; Dhatariya K
J Diabetes Complications; 2011; 25(5):346-8. PubMed ID: 21106397
[TBL] [Abstract][Full Text] [Related]
36. [The optimization of the infusion therapy procedure in patients with acute leukemias].
Moiseev SI; Abdulkadyrov KM
Ter Arkh; 1996; 68(10):41-4. PubMed ID: 9026941
[TBL] [Abstract][Full Text] [Related]
37. Pyomyositis in children: early diagnosis and treatment.
Mitsionis GI; Manoudis GN; Lykissas MG; Sionti I; Motsis E; Georgoulis AD; Berisa AE
J Pediatr Surg; 2009 Nov; 44(11):2173-8. PubMed ID: 19944229
[TBL] [Abstract][Full Text] [Related]
38. Acute lymphoblastic leukaemia presenting as breast mass.
Jain AK; Gupta RC; Bhardwaj B; Leelani N
J Assoc Physicians India; 1992 May; 40(5):335-6. PubMed ID: 1483996
[TBL] [Abstract][Full Text] [Related]
39. Bilateral obturator pyomyositis with visceral involvement in an immunocompetent adult patient treated without surgery.
Karakatsanis A; Lykoudis P; Nastos C; Chronopoulos E; Koutoulidis V; Polymeneas G; Voros D
Surg Infect (Larchmt); 2014 Oct; 15(5):651-5. PubMed ID: 24865387
[TBL] [Abstract][Full Text] [Related]
40. [Report on induction efficacy of protocol ALL-2005 and middle term follow-up of 158 cases of childhood acute lymphoblastic leukemia].
Tang JY; Gu LJ; Xue HL; Chen J; Pan C; Wu WT; Shen SH; Dong L; Zhou M; Ye QD; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):289-93. PubMed ID: 19799121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
